| Colistin alone versus colistin plus meropenem for treatment of severe infections caused by carbapenem-resistant Gram-negative bacteria: an open-label, randomised controlled trial M Paul, GL Daikos, E Durante-Mangoni, D Yahav, Y Carmeli, YD Benattar, ... The lancet Infectious diseases 18 (4), 391-400, 2018 | 520 | 2018 |
| Cost-effectiveness of diabetic retinopathy screening programs using telemedicine: a systematic review D Avidor, A Loewenstein, M Waisbourd, A Nutman Cost Effectiveness and Resource Allocation 18, 1-9, 2020 | 117 | 2020 |
| Treatment Outcomes of Colistin- and Carbapenem-resistant Acinetobacter baumannii Infections: An Exploratory Subgroup Analysis of a Randomized Clinical Trial Y Dickstein, J Lellouche, M Ben Dalak Amar, D Schwartz, A Nutman, ... Clinical Infectious Diseases 69 (5), 769-776, 2019 | 100 | 2019 |
| Eplerenone for chronic central serous chorioretinopathy–A randomized controlled prospective study R Schwartz, Z Habot‐Wilner, MR Martinez, A Nutman, D Goldenberg, ... Acta ophthalmologica 95 (7), e610-e618, 2017 | 100 | 2017 |
| A case-control study to identify predictors of 14-day mortality following carbapenem-resistant Acinetobacter baumannii bacteraemia A Nutman, R Glick, E Temkin, M Hoshen, R Edgar, T Braun, Y Carmeli Clinical Microbiology and Infection 20 (12), O1028-O1034, 2014 | 87 | 2014 |
| An outbreak of carbapenem-resistant Acinetobacter baumannii in a COVID-19 dedicated hospital T Gottesman, R Fedorowsky, R Yerushalmi, J Lellouche, A Nutman Infection prevention in practice 3 (1), 100113, 2021 | 76 | 2021 |
| Prediction of emergency department visits for respiratory symptoms using an artificial neural network H Bibi, A Nutman, D Shoseyov, M Shalom, R Peled, S Kivity, J Nutman Chest 122 (5), 1627-1632, 2002 | 71 | 2002 |
| Colistin plus meropenem for carbapenem-resistant Gram-negative infections: In vitro synergism is not associated with better clinical outcomes A Nutman, J Lellouche, E Temkin, G Daikos, A Skiada, ... Clinical Microbiology and Infection 26 (9), 1185-1191, 2020 | 66 | 2020 |
| Carriage of extended-spectrum beta-lactamase–producing Enterobacteriaceae and the risk of surgical site infection after colorectal surgery: a prospective cohort study B Dubinsky-Pertzov, E Temkin, S Harbarth, C Fankhauser-Rodriguez, ... Clinical Infectious Diseases 68 (10), 1699-1704, 2019 | 63 | 2019 |
| Evaluation of carriage and environmental contamination by carbapenem-resistant Acinetobacter baumannii A Nutman, A Lerner, D Schwartz, Y Carmeli Clinical microbiology and infection 22 (11), 949. e5-949. e7, 2016 | 53 | 2016 |
| Influenza vaccination motivators among healthcare personnel in a large acute care hospital in Israel A Nutman, N Yoeli Israel Journal of Health Policy Research 5, 1-7, 2016 | 52 | 2016 |
| Multicentre open-label randomised controlled trial to compare colistin alone with colistin plus meropenem for the treatment of severe infections caused by carbapenem-resistant … Y Dickstein, L Leibovici, D Yahav, N Eliakim-Raz, GL Daikos, A Skiada, ... BMJ open 6 (4), e009956, 2016 | 51 | 2016 |
| Observational cohort study of IP-10’s potential as a biomarker to aid in inflammation regulation within a clinical decision support protocol for patients with severe COVID-19 S Lev, T Gottesman, G Sahaf Levin, D Lederfein, E Berkov, D Diker, ... Plos one 16 (1), e0245296, 2021 | 50 | 2021 |
| How to: molecular investigation of a hospital outbreak A Nutman, D Marchaim Clinical Microbiology and Infection 25 (6), 688-695, 2019 | 46 | 2019 |
| The association between empirical antibiotic treatment and mortality in severe infections caused by carbapenem-resistant gram-negative bacteria: a prospective study Y Zak-Doron, Y Dishon Benattar, I Pfeffer, GL Daikos, A Skiada, ... Clinical infectious diseases 67 (12), 1815-1823, 2018 | 43 | 2018 |
| Personalized ertapenem prophylaxis for carriers of extended-spectrum β-lactamase–producing Enterobacteriaceae undergoing colorectal surgery A Nutman, E Temkin, S Harbarth, B Carevic, F Ris, ... Clinical Infectious Diseases 70 (9), 1891-1897, 2020 | 37 | 2020 |
| Outbreak of adenovirus type 55 infection in Israel M Salama, Z Amitai, A Nutman, T Gottesman-Yekutieli, H Sherbany, ... Journal of Clinical Virology 78, 31-35, 2016 | 37 | 2016 |
| Primary intraspinal primitive neuroectodermal tumor treated with autologous stem cell transplantation: case report and review of the literature A Nutman, S Postovsky, I Zaidman, R Elhasid, E Vlodavsky, Y Kreiss, ... Pediatric Hematology and Oncology 24 (1), 53-61, 2007 | 35 | 2007 |
| Predictors of pandemic (H1N1) 2009 virus positivity and adverse outcomes among hospitalized patients with a compatible syndrome A Shlomai, A Nutman, T Kotlovsky, V Schechner, Y Carmeli, ... IMAJ-Israel Medical Association Journal 12 (10), 622, 2010 | 32 | 2010 |
| Combining VITEK® 2 with colistin agar dilution screening assist timely reporting of colistin susceptibility J Lellouche, D Schwartz, N Elmalech, MAB Dalak, E Temkin, M Paul, ... Clinical Microbiology and Infection 25 (6), 711-716, 2019 | 29 | 2019 |
